Imaging review can be a separate cost step
A specialist team may need current contrast MRI, temporal-bone CT and earlier scans to assess growth and anatomy. Repeat imaging can be requested when outside studies are incomplete, outdated or not suitable for treatment planning.
Angiography and embolization can add a separate procedural episode
Selected vascular tumors may undergo catheter angiography and preoperative embolization. These involve neuroradiology, contrast, catheter-lab resources, materials, monitoring and sometimes an additional admission, so they should be clarified separately from the surgical estimate.
Surgical costs vary with jugular-foramen and temporal-bone anatomy
Operative complexity changes with tumor size, intracranial extension, carotid involvement, hearing status, prior treatment and the expected need for reconstruction. A limited tympanic lesion and a large jugular-foramen tumor are not equivalent cases.
Radiotherapy and radiosurgery have their own planning costs
Stereotactic radiosurgery or fractionated stereotactic radiotherapy involves consultation, planning imaging, contouring, dosimetry, quality assurance and treatment delivery. The estimate depends on technique, fractionation, tumor size and previous radiation.
Biochemical and genetic testing may be clinically important
When indicated, plasma metanephrines/methoxytyramine and hereditary-paraganglioma genetic testing can add laboratory and counseling costs. These are particularly relevant for functional, multifocal, young-onset or family-history cases.
Hearing, swallowing and voice support can add costs
Baseline audiology and cranial-nerve assessment may be needed before treatment. Post-treatment speech/swallowing therapy, nutrition support, hearing rehabilitation or ENT follow-up can fall outside the core surgery or radiotherapy quotation.
Observation still has a real long-term cost
A wait-and-scan strategy avoids immediate procedural expense but requires serial MRI, hearing/cranial-nerve review and specialist interpretation over time. International patients should decide whether surveillance will be performed locally or in Germany.
Previous treatment changes the estimate
Recurrent tumors after surgery, embolization or radiotherapy often require more complex imaging review and treatment planning. Previous operative reports, angiography and radiation dose distributions should be supplied before requesting a new quote.
Complications and prolonged admission can increase the final invoice
Cranial-nerve deficits, swallowing problems, aspiration, CSF leak, vascular complications, wound problems or rehabilitation needs can extend admission and increase costs beyond the initial estimate. Ask how unplanned care is handled in the self-pay agreement.
Send complete records before requesting a quotation
The estimate is most useful after a clear treatment recommendation.
- Current skull-base MRI DICOM files
- Temporal-bone/skull-base CT if available
- Earlier imaging for growth comparison
- ENT/audiology and hearing-test results
- Cranial-nerve, swallowing and voice assessments
- Angiography or embolization reports if already performed
- Metanephrine/methoxytyramine results if available
- Genetic test results including SDHx genes if available
- Operative and radiotherapy reports for previously treated disease
- Requested service: observation review, surgery, embolization, radiotherapy/radiosurgery or recurrence review
Official sources
Last source-reviewed 2026-09-05. Cost procedures and published service fees can change, so confirm current terms directly with the provider before transferring money or booking travel.
- Heidelberg Skull Base Center – glomus tumors — Heidelberg University Hospital ↗
- Heidelberg Neuroradiology – glomus tumor MRI and embolization — Heidelberg University Hospital ↗
- Head and neck paragangliomas: recent advances and patient-care guidance — Endocrine Reviews ↗
- 2025 head-and-neck paraganglioma guideline appraisal — Annals of Surgical Oncology ↗